Colgate has introduced new Colgate Total* with a different active ingredient that delivers even more benefits than the earlier version of Colgate Total* with triclosan that it replaces. New Colgate Total*, the earlier formula of Colgate Total*, and all of our products are introduced following a rigorous safety evaluation. Further, Colgate recognizes the importance of continuous scientific study. We conduct and commission research, publish papers, closely investigate newly published information, and actively participate in expert symposia on an ongoing basis. We remain confident that ongoing independent scientific reviews will continue to add to the substantial body of research that affirms the safety and effectiveness of the earlier formula of Colgate Total* with triclosan.

Safety reviews of triclosan in toothpaste by regulators around the world

The U.S. Food and Drug Administration (FDA), leading health regulatory agencies around the world, and other independent sources have reviewed and confirmed triclosan's safe and effective use in the earlier Colgate Total* toothpaste.

The earlier Colgate Total*, with its active ingredient triclosan, has been approved as safe and effective by the FDA via its rigorous New Drug Application (NDA) process. This is the same process used by the FDA to approve prescription medications, and the earlier version of Colgate Total* is the only toothpaste that has undergone the FDA's NDA review process. The NDA approval process requires a comprehensive evaluation of human safety. All new drug assessments include a review of nonclinical studies covering a wide array of toxicological endpoints, such as carcinogenicity, reproductive and developmental toxicity, eye and skin irritation, and short term and long term toxicity. The FDA's NDA approval also requires ongoing monitoring and updating, and we regularly provide the FDA with safety updates.

Learn about the additional benefits offered by new Colgate Total*

On September 6, 2016, the FDA published its final rule on consumer antibacterial hand soaps that prohibits the continued use of triclosan and 18 other antibacterial ingredients, as of September 6, 2017. The FDA concluded that soap manufacturers had not submitted adequate safety evidence for use in these products; the agency did not conclude that triclosan in soap is unsafe. The FDA's rule with respect to consumer antibacterial hand soaps does not impact the NDA approval of the earlier formula of Colgate Total's*, which has not changed.

For more information about how New Drug Applications get approved by FDA, please click here.  For additional information regarding triclosan and the FDA, click here.

Independent scientific committees of the European Commission have also evaluated the safety of triclosan several times (the Scientific Committee on Cosmetic Products and Non-food Products in 2002, the Scientific Committee on Consumer Products in 2002 and 2006, and the Scientific Committee on Consumer Safety in 2011.) Each concluded that triclosan use at 0.3% in toothpaste, the level found in the original formula of our toothpaste, is considered safe. Accordingly, an April 2014 amendment to the EU Cosmetic Regulation confirmed triclosan's continued use in cosmetic toothpastes up to the approved 0.3% level.

In addition to US FDA and the EU Commission reviews, the two EU medicinal authorities who have reviewed Colgate Total* with triclosan, the UK and Irish Medicinal Authorities (MHRA and HPRA), have both approved it as a safe and effective medicinal toothpaste, as have the comparable health authorities in Canada, Australia, and New Zealand.

We will continue to share scientific research with regulatory bodies responsible for public health around the world, and remain confident that ongoing independent scientific reviews will continue to add to the substantial body of research that affirms the safety and effectiveness of the earlier Colgate Total* formulated with triclosan.